Valuation: Proto Script Pharmaceutical Corp.

Market Cap 1.97M 1.7M 1.6M 1.45M 2.73M 188M 2.77M 18.74M 7.34M 94.19M 7.38M 7.22M 314M P/E 2015 *
-
P/E 2016 -41.4x
Enterprise Value 2.01M 1.74M 1.64M 1.49M 2.8M 193M 2.84M 19.19M 7.52M 96.48M 7.56M 7.4M 321M EV / Sales 2015 *
-
EV / Sales 2016 394x
Free-Float
89.82%
Yield 2015 *
-
Yield 2016 -
1 week-50.00%
Current month-50.00%
1 month-50.00%
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 1.0E-6
2.2
Manager TitleAgeSince
Chief Executive Officer 58 2016-06-28
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-50.00%-.--%-98.00% 11.38K
+1.13%-2.58%-6.67%+64.78% 79.16B
+0.18%-2.41%-1.86%+7.87% 16.81B
-0.76%-2.52%+2.77%+12.56% 14.21B
-0.09%+0.17%+25.70%+44.27% 12.18B
-1.64%-5.59%+18.47%+100.45% 8.12B
-0.34%+2.53%+53.06%+146.06% 7.11B
+3.10%+2.49%-21.02%-4.14% 5.66B
-0.15%-3.04%+18.62%-0.67% 5.38B
+3.08%+2.09%-17.48%+28.30% 5.24B
Average +0.46%-0.89%+7.16%+30.15% 15.39B
Weighted average by Cap. +0.64%-1.47%+1.36%+51.69%

Financials

2015 2016
Net sales 881K 761K 716K 651K 1.22M 84.45M 1.24M 8.4M 3.29M 42.24M 3.31M 3.24M 141M 789K 681K 641K 583K 1.1M 75.59M 1.11M 7.52M 2.95M 37.81M 2.96M 2.9M 126M
Net income -145K -125K -118K -107K -202K -13.92M -205K -1.38M -543K -6.96M -545K -533K -23.18M -7.18M -6.2M -5.84M -5.3M -9.98M -688M -10.12M -68.47M -26.83M -344M -26.97M -26.38M -1.15B
Net Debt 27.07K 23.38K 22K 19.99K 37.6K 2.59M 38.15K 258K 101K 1.3M 102K 99.42K 4.32M 47.78K 41.27K 38.83K 35.29K 66.38K 4.58M 67.35K 455K 179K 2.29M 179K 176K 7.63M
Logo Proto Script Pharmaceutical Corp.
Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company's health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.
Employees
13
  1. Stock Market
  2. Stocks
  3. PSCR Stock